Corona Remedies Ltd

{"amount":10}

{"actualRevenue":3530900000,"estimateRevenue":3391000000,"revenueSurprise":139900000,"revenueSurprisePercent":4.125626658802713,"actualEPS":7.41,"estimateEPS":6.464,"surprise":0.9459999999999997,"surprisePercent":14.634900990099}

{"description":"Corona Remedies Ltd made a strong debut on December 15, 2025, listing at a 38.42% premium over its IPO price of Rs 1,062. The Rs 655-crore IPO was oversubscribed 144.5 times, reflecting high investor confidence in the company's financial health and growth potential.","url":"https://timesofindia.indiatimes.com/business/india-business/corona-remedies-listing-today-stock-makes-stellar-entry-on-dalal-street-lists-at-38-premium-over-issue-price/articleshow/125970695.cms","sentiment":"Positive","domain":"Indiatimes"}

{"description":"Corona Remedies Ltd made a strong debut on the stock market, with shares listing at a 38% premium after selling in the price band of Rs 1,008-1,062. This positive performance indicates strong investor interest and confidence in the company.","url":"https://www.msn.com/en-in/money/other/corona-remedies-make-a-strong-stock-market-debut-shares-list-at-38-premium/ar-AA1SlM8M?ocid=BingNewsVerp","sentiment":"Positive","domain":"Business Today on MSN"}

{"description":"Corona Remedies IPO is set to list on BSE and NSE on December 15, 2025, following a successful subscription from December 8 to 10, with 137.04 times oversubscription. The grey market premium indicates a potential listing price of Rs 1,372, a 29.19% increase from the upper price band of Rs 1,062.","url":"https://www.ndtvprofit.com/ipos/corona-remedies-ipo-listing-date-gmp-signals-25-listing-pop-for-investors","sentiment":"Positive","domain":"NDTV Profit"}

{"description":"The IPO of Corona Remedies Ltd closed with an impressive 137x subscription on its third day, indicating strong investor interest. This high demand could positively influence the company's stock performance post-listing.","url":"https://www.moneycontrol.com/news/business/ipo/corona-remedies-ipo-subscribed-32x-on-day-3-so-far-nii-portion-booked-107x-check-latest-gmp-13719281.html","sentiment":"Positive","domain":"moneycontrol.com"}

{"description":"The Corona Remedies IPO, which launched on December 8, has seen strong demand, being subscribed 108.28 times, particularly by Non-Institutional Investors. The grey market premium reached Rs 325, suggesting a potential listing price of Rs 1,387 per share on December 15.","url":"https://www.ndtvprofit.com/ipos/corona-remedies-ipo-gmp-what-does-grey-market-trends-suggest-on-final-day-of-subscription","sentiment":"Positive","domain":"NDTV Profit"}